Stock Events

Stock Events

Global X Genomics & Biotechnology UCITS USD Acc 

£9.03
47
-£0.26-2.76% 16:35 Today

Statistics

Day High
9.38
Day Low
8.97
52W High
10.01
52W Low
4.84
Volume
16,962
Avg. Volume
27,142
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Expense Ratio

0.50%
0%
1%+
The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GNOG.LSE. It's not an investment recommendation.
Microsoft
7
MSFT
Realty Income
7
O
Coca-Cola
7
KO
Johnson & Johnson
6
JNJ

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
ARK Genomic Revolution
ARKG
Mkt Cap0
ARK Genomic Revolution ETF focuses on companies likely to benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, genomics, and biotechnology, similar to GNOG.LSE.
VanEck Biotech
BBH
Mkt Cap0
VanEck Vectors Biotech ETF includes holdings in biotechnology companies involved in the use of biological processes to develop products or provide services, akin to the focus of GNOG.LSE.
First Trust NYSE Arca Biotechnology Index Fund
FBT
Mkt Cap0
First Trust NYSE Arca Biotechnology Index Fund tracks an index of biotechnology and pharmaceutical companies, competing directly in the biotech sector like GNOG.LSE.
iShares Biotechnology
IBB
Mkt Cap0
iShares Nasdaq Biotechnology ETF represents biotechnology and pharmaceutical companies, directly competing with GNOG.LSE in the biotech investment space.
State Street SPDR S&P Biotech
XBI
Mkt Cap0
SPDR S&P Biotech ETF provides exposure to biotechnology companies, a direct competitor to GNOG.LSE's focus on genomics and biotechnology sectors.
Invesco Biotechnology & Genome
PBE
Mkt Cap0
Invesco Dynamic Biotechnology & Genome ETF targets companies in the biotechnology and genome industry, closely aligning with GNOG.LSE's investment focus.
Global X Genomics & Biotechnology
GNOM
Mkt Cap0
Global X Genomics & Biotechnology ETF is another fund by Global X, specifically focusing on genomics and biotechnology, directly competing with GNOG.LSE.
iShares Genomics Immunology and Healthcare
IDNA
Mkt Cap0
Principal Healthcare Innovators Index
BTEC
Mkt Cap0
Principal Healthcare Innovators Index ETF focuses on small and mid-cap companies in the healthcare sector, including biotechnology and genomics, overlapping with GNOG.LSE's market.
ALPS Medical Breakthroughs
SBIO
Mkt Cap0
ALPS Medical Breakthroughs ETF targets companies with one or more drugs in Phase II or Phase III FDA clinical trials, competing in the innovative biotech space like GNOG.LSE.

Holdings

Regions

Sectors

About

The Global X Genomics & Biotechnology UCITS ETF (GNOM LN) is designed to replicate the overall financial performance of the Solactive Genomics v2 Index. This includes mirroring both the index's price movements and its income generation, prior to the deduction of fund fees and operating expenses.
Show More
CEO
Country
Ireland
ISIN
IE00BM8R0N95
WKN
000A2QRCP

Listings

MI
IT
GNOM.MI
MU
DE
GN0M.MU
XETRA
DE
GN0M.XETRA
LSE
GB
GNOG.LSE

0 Comments

Share your thoughts

FAQs

What is Global X Genomics & Biotechnology UCITS USD Acc stock price today?▼
The current price of GNOG.LSE is £9.03 GBP — it has decreased by -2.76% in the past 24 hours. Watch Global X Genomics & Biotechnology UCITS USD Acc stock price performance more closely on the chart.
What is Global X Genomics & Biotechnology UCITS USD Acc stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on London Exchange exchange Global X Genomics & Biotechnology UCITS USD Acc stocks are traded under the ticker GNOG.LSE.
Is Global X Genomics & Biotechnology UCITS USD Acc stock price growing?▼
GNOG.LSE stock has risen by +1.76% compared to the previous week, the month change is a -3.66% fall, over the last year Global X Genomics & Biotechnology UCITS USD Acc has showed a +48.11% increase.
In which sector is Global X Genomics & Biotechnology UCITS USD Acc located?▼
Global X Genomics & Biotechnology UCITS USD Acc operates in the Finance & Payments sector.
When did Global X Genomics & Biotechnology UCITS USD Acc complete a stock split?▼
Global X Genomics & Biotechnology UCITS USD Acc has not had any recent stock splits.
Where is Global X Genomics & Biotechnology UCITS USD Acc headquartered?▼
Global X Genomics & Biotechnology UCITS USD Acc is headquartered in Dublin, Ireland.